A new study shows that repeated, low-doses of psilocybin lead to a significant reduction in the number of cluster...
Search Results
Psilocybin and Migraine Disease
Joint research project by Clusterbusters INC. and Cluster Headache - Trigeminal Autonomic Cephalahia (CH-TAC), LLC...
Initial Results: Clinical Trial of Psilocybin for Cluster Headache
The first results of a small randomized controlled study of psilocybin for cluster headache have been published in the...
Calls for psilocybin access rights for UK cluster headache sufferers
Backed by three top psychiatrists, 161 cluster headache sufferers in the UK have written an open letter to Home Office...
The Case for Rescheduling Psilocybin x CDPRG
In September 2020, the APPG for Drug Policy Reform heard expert commentary from the front lines of the UK's battle...
Could Psilocybin be the Next Migraine and Cluster Headaches Treatment?
Migraine and cluster headache (CH) are both ongoing conditions that severely impact a patient’s quality of life and are significant causes of disability.
Although treatments are available for both conditions, medications have been known to be ineffective and cause unpleasant side-effects in a significant number of patients.
Evidence has shown that psilocybin – the psychoactive ingredient in magic mushrooms – alongside other drugs which interact with the 5-HT2A receptor, like LSD, have long-lasting effects reducing migraine and CH frequency in patients.
Psilocybin and LSD in the Treatment of Cluster Headache
The Theory and Protocols This treatment, commonly referred to as 'busting' is a way of using hallucinogenic...